The performance of companies tied to blockbuster drugs like Viagra presents a complex investment scenario . While the initial boom of copyright, fueled by Viagra's remarkable popularity, generated substantial returns, the patent expiration in key markets has introduced significant volatility. Investors are now assessing the impact of rival medicati